Similar articles

• Insulin-like growth factor-1 receptor polymorphism and ischemic stroke: a case-control study in Chinese population.

  Cheng J, Liu J, Li X, Peng J, Han S, Zhang R, Xu Y, Nie S. Cheng J, et al. Acta Neurol Scand. 2008 Nov;118(5):333-8. doi: 10.1111/j.1600-0404.2008.01040.x. Epub 2008 May 9. Acta Neurol Scand. 2008. PMID: 18477064
• Effect of genetic modifiers on cerebral lesions in Fabry disease.

  Altarescu G, Moore DF, Schiffmann R. Altarescu G, et al. Neurology. 2005 Jun 28;64(12):2148-50. doi: 10.1212/01.WNL.0000166000.24321.4F. Neurology. 2005. PMID: 15985593
• [Genetic testing for Marfan syndrome].

  Mizuguchi T, Matsumoto N. Mizuguchi T, et al. Nihon Rinsho. 2005 Dec;63 Suppl 12:427-30. Nihon Rinsho. 2005. PMID: 16416828 Review. Japanese. No abstract available.
• Is TGFBR1*6A really associated with increased risk of cancer?

  Zhang HT, Zhao J, Zheng SY, Chen XF. Zhang HT, et al. J Clin Oncol. 2005 Oct 20;23(30):7743-4; author reply 7744-6. doi: 10.1200/JCO.2005.02.9108. J Clin Oncol. 2005. PMID: 16234535 Review. No abstract available.
• Factor v Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke.

  Simchen MJ, Goldstein G, Lubetsky A, Strauss T, Schiff E, Kenet G. Simchen MJ, et al. Stroke. 2009 Jan;40(1):65-70. doi: 10.1161/STROKEAHA.108.527283. Epub 2008 Oct 16. Stroke. 2009. PMID: 18927445